Tag: Bioversys AG

MLLStart! advised Clinical Research Ventures (CR Ventures) in its investment into BioVersys AG in a Series C financing round

Start-up desk MLLStart! advised Clinical Research Ventures (CR Ventures), a global life-science investor with a focus on companies entering Phase I or II clinical trials based in Boston, USA, in its investment in a Series C financing round of BioVersys AG, a privately-held clinical-stage, multi-asset Swiss pharmaceutical company focusing on research and development of therapies…